Gynaecology and Obstetrics Ward, Specialist Hospital, Zakopane, Poland.
Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland.
Ginekol Pol. 2020;91(4):216-222. doi: 10.5603/GP.2020.0043.
The aim of the study was to assess the utility of mid-trimester ultrasound parameters in predicting birth weight in low-risk pregnancy and high-risk pregnancy complicated with pregestational diabetes mellitus.
A study group comprised 97 healthy women and 160 women with pregestational diabetes (PGDM, type 1), all in singleton pregnancy. Ultrasound examination was performed between weeks 11 and 14, and in weeks 20 and 30 of gestation, based on recommendations of the Polish Society of Gynecologists and Obstetricians, Ultrasonography Division. We also checked uterine artery blood flow parameters.
There is a correlation between the birth weight and ultrasound-ascertained parameters, including those characterising uterine artery blood flow and foetal biometry [abdominal circumference (AC), femoral length (FL), biparietal dimension (BPD)].The biparietal dimension (BPD), head circumference (HC) abdominal circumference (AC) and pre-existing diabetes are the ultrasound predictors of LGA. The presence of an early-diastolic uterine artery blood flow waveform notching, as well as the uterine artery pulsatility index (UAPI), femoral length (FL) and hypertension in pregnancy are the ultrasound predictors of SGA. In the subset of women with pre-gestational diabetes (PGDM), there is a negative correlation between the birth weight and the uterine artery pulsatility index and early-diastolic uterine artery blood flow waveform notching. In women with pre-gestational diabetes mellitus (PGDM), femoral length (FL) is a significant predictor of LGA and in case of SGA significant predictors are uterine artery pulsatility index, artery blood flow waveform notching and femoral length (FL).
Midtrimester ultrasound parameters with confirmed usefulness in the prediction of birth weight in low-risk pregnancy and high-risk pregnancy complicated with pregestational diabetes mellitus include: uterine artery PI, early-diastolic uterine artery blood flow waveform notching and foetal biometry.
本研究旨在评估中孕期超声参数在预测低危妊娠和伴有孕前糖尿病的高危妊娠中胎儿出生体重的作用。
研究组包括 97 例健康孕妇和 160 例孕前糖尿病(PGDM,1 型)孕妇,均为单胎妊娠。根据波兰妇科和产科医师协会、超声科的建议,分别在妊娠 11-14 周和 20-30 周进行超声检查。我们还检查了子宫动脉血流参数。
胎儿出生体重与超声确定的参数之间存在相关性,包括子宫动脉血流和胎儿生物测量参数(腹围(AC)、股骨长(FL)、双顶径(BPD))。双顶径(BPD)、头围(HC)、腹围(AC)和孕前糖尿病是巨大儿(LGA)的超声预测指标。早孕期舒张末期子宫动脉血流切迹、子宫动脉搏动指数(UAPI)、股骨长(FL)和妊娠高血压是胎儿生长受限(SGA)的超声预测指标。在孕前糖尿病(PGDM)妇女亚组中,出生体重与子宫动脉搏动指数和早孕期舒张末期子宫动脉血流切迹呈负相关。在孕前糖尿病妇女中,股骨长(FL)是巨大儿的显著预测指标,而对于胎儿生长受限,显著预测指标是子宫动脉搏动指数、血流切迹和股骨长(FL)。
在预测低危妊娠和伴有孕前糖尿病的高危妊娠中胎儿出生体重方面,中孕期超声参数具有确认的作用,包括:子宫动脉 PI、早孕期舒张末期子宫动脉血流切迹和胎儿生物测量。